Back

The impact of baseline right heart size and function on heart failure hospitalization and mortality: 2-year results of the TRILUMINATE Trial

31 August 2025 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: Estimating prognosis after atrial ventricular: valvular intervention Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Rebecca Hahn

Columbia University Medical Centre, New York (United States of America)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on estimating prognosis after atrial ventricular: valvular intervention
Professor E. Donal (Rennes, FR)
Slides Video
Presentation thumbnail
Left ventricular ejection fraction and benefit of tricuspid valve interventions: Insights from the international TRIGISTRY
Doctor G. Heitzinger (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Predictive factors for persisting excess symptoms following transcatheter edge-to-edge repair for degenerative mitral regurgitation: Results of the worldwide, multicenter PRIME-MR registry
Doctor B. Koell (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Impact of periprocedural pulmonary hypertension on outcomes after mitral valve transcatheter edge-to-edge repair
Doctor J. Miyamoto (Kanagawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Estimating prognosis after atrial ventricular: valvular intervention
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 08:33 CET
You may be interested in
thumbnail
Congress Session
Estimating prognosis after atrial ventricular: valvular intervention
thumbnail
Congress Presentation
TRISCEND II trial: TTVR outcomes by baseline TR severity
thumbnail
Congress Session
The right ventricle in heart failure: forget me not

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources